文献速递术前评估与围术期医学疼痛医学

围术期流程与患者报告结局对持续性术后阿片使用的影响

How perioperative processes and patient-reported outcomes contribute to persistent postoperative opioid use: A cohort study linking clinical and health claims data.
PubMed 文献 · Eur J Anaesthesiol · 2025-09-03

结果显示7.8%患者出现持续性术后阿片使用(PPOU)。术前阿片使用(aOR=20.8)和抑郁(aOR=1.85)是患者特异性风险因素;住院期间阿片给药与PPOU绝对风险增加4%相关,术后第一天最高疼痛强度每增加1分(11点NRS)与绝对风险增加0.5%相关,而术后恶心与绝对风险降低2.6%相关。

要点

  • 术前阿片使用和抑郁是PPOU的强患者特异性风险因素。
  • 住院期间阿片给药(尤其病房内)与PPOU绝对风险增加4%相关。
  • 术后第一天更高疼痛强度增加PPOU风险,术后恶心与风险降低相关。

核心结论

  • 围术期阿片类药物显著增加持续性术后阿片使用(PPOU)风险,需审慎管理术后阿片处方。
  • 有效及时地处理疼痛并减少病房内阿片处方可能降低PPOU。

研究设计与样本

  • 前瞻性队列研究,将QUIPS疼痛注册围术期数据与BARMER医保索赔数据链接。

主要发现

  • 总体7.8%患者出现PPOU。
  • 术前阿片使用aOR=20.8(P<0.001),抑郁aOR=1.85(P=0.006)。
  • 住院期间阿片给药与PPOU调整绝对风险增加4%相关(P=0.001),病房内阿片尤为突出。
  • 术后第一天最高疼痛强度每增加1分(11点NRS)与绝对PPOU风险增加0.5%相关(P=0.023)。
  • 术后恶心(是 vs 否)与绝对PPOU风险降低2.6%相关(P=0.034)。

临床怎么用

  • 术前识别阿片使用和抑郁患者,针对性优化围术期镇痛方案。
  • 减少病房内阿片处方,加强术后疼痛早期有效管理以降低PPOU风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid analgesics play a major role in perioperative pain management, yet their use can lead to persistent postoperative opioid use (PPOU), with significant societal and health costs. Patient-specific risk factors of PPOU are well described but little is known about factors that can be controlled by clinicians. OBJECTIVES: To find PPOU risk factors among perioperative processes and pain-related patient-reported outcomes (PROs) on the first postoperative day. DESIGN: Prospective cohort study linking perioperative data from Quality Improvement in Postoperative Pain Treatment (QUIPS) pain registry with health claims data from BARMER insurance. SETTING: Thirty-one German hospitals in 2021. PATIENTS: We analysed 1849 of 1994 patients undergoing surgery (mean age = 61.6 years ± 17.3, 60.7% women). Exclusion criteria: under 18 years, unable to communicate, not consenting, failed data linkage. MAIN OUTCOME MEASURE: Persistent postoperative opioid use (PPOU), defined as at least one opioid prescription within 90 days postdischarge and another one between days 91 and 180. RESULTS: Overall, 7.8% of patients showed PPOU. In logistic regression models, preadmission opioid use, adjusted odds ratio (aOR) = 20.8, P < 0.001, and depression, aOR = 1.85, P = 0.006, were patient-specific risk factors. Opioid administration during the hospital stay was associated with 4% increase in adjusted absolute PPOU risk ( P = 0.001), with opioids on the ward standing out. Among PROs on the first postoperative day, higher maximal pain intensity (0.5% per point on 11-point Numeric Rating Scale, P = 0.023) was associated with an increased absolute PPOU risk while postoperative nausea (2.6% if yes, P = 0.034) was associated with a decreased absolute risk. CONCLUSIONS: Perioperative opioids significantly contributed to the risk of PPOU, emphasising the need for careful opioid management postsurgery. Addressing pain effectively and promptly, while minimising opioid prescriptions on the ward, may reduce PPOU. Further research is needed to refine pain management and optimise patient outcomes.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Komann M, Arnold C, Dreiling JT, et al. How perioperative processes and patient-reported outcomes contribute to persistent postoperative opioid use: A cohort study linking clinical and health claims data. Eur J Anaesthesiol. 2025. PMID: 40905237. doi:10.1097/EJA.0000000000002265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。